OKUR 8-K 2026-08-12

OnKure Therapeutics, Inc. (OKUR) 8-K dated 2026-08-12 — accession 0001193125-26-347315. This URL is the filing, not the OKUR hub.

OnKure Therapeutics, Inc. (OKUR) is a biotechnology company listed on US.

OnKure Therapeutics, Inc. filed a 8-K on 2026-08-12. Accession 0001193125-26-347315.

Cached items: 5.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported OKUR revenue for 2026-06-30 was $2.0M. Net income was -$30.5M. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.

Not investment advice. The OKUR SEC hub lists recent forms. The stock page is the research view.